E. Radeczky
- Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: Design and planned analysesBy P. Paggiaro, M. Engel, N. Tudoric, B. Forstner, E. Radeczky, V. Zubek, Z. Blahova and P. Moroni-ZentgrafP. Paggiaro1Dipartimento Cardio-Toracico, Respiratory Pathophysiology, University of Pisa, Pisa, ItalyM. Engel2TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, GermanyN. Tudoric3University Hospital Dubrava, Zagreb, CroatiaB. Forstner4Pneumological pract. Forstner MD, Wels, AustriaE. Radeczky5Men For Care Szazhalom Health Center, Százhalombatta, HungaryV. Zubek6Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United StatesZ. Blahova7Clinical Development, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, AustriaP. Moroni-Zentgraf2TA Respiratory Diseases, Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.